Cargando…

Raxibacumab: potential role in the treatment of inhalational anthrax

Anthrax is a highly contagious and potentially fatal human disease caused by Bacillus anthracis, an aerobic, Gram-positive, spore-forming rod-shaped bacterium with worldwide distribution as a zoonotic infection in herbivore animals. Bioterrorist attacks with inhalational anthrax have prompted the de...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kummerfeldt, Carlos E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011807/ https://www.ncbi.nlm.nih.gov/pubmed/24812521 http://dx.doi.org/10.2147/IDR.S47305

Ejemplares similares

Approval of Raxibacumab for the Treatment of Inhalation Anthrax Under the US Food and Drug Administration “Animal Rule”
por: Tsai, Chia-Wei, et al.
Publicado: (2015)

Bacillus anthracis Protective Antigen Kinetics in Inhalation Spore-Challenged Untreated or Levofloxacin/Raxibacumab-Treated New Zealand White Rabbits
por: Corey, Alfred, et al.
Publicado: (2013)

Evaluating Detection of an Inhalational Anthrax Outbreak
por: Buckeridge, David L., et al.
Publicado: (2006)

Investigation of Inhalation Anthrax Case, United States
por: Griffith, Jayne, et al.
Publicado: (2014)

Raxibacumab augments hemodynamic support and improves outcomes during shock with B. anthracis edema toxin alone or together with lethal toxin in canines
por: Remy, Kenneth E, et al.
Publicado: (2015)

The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax
por: Coggeshall, Kenneth Mark, et al.
Publicado: (2013)

A case report of inhalation anthrax acquired naturally
por: Azarkar, Zohreh, et al.
Publicado: (2016)

Teixobactin Provides Protection against Inhalation Anthrax in the Rabbit Model
por: Lawrence, William S., et al.
Publicado: (2020)

Bioterrorism-related Inhalational Anthrax in an Elderly Woman, Connecticut, 2001
por: Griffith, Kevin S., et al.
Publicado: (2003)

Combination Therapy with Antibiotics and Anthrax Immune Globulin Intravenous (AIGIV) Is Potentially More Effective than Antibiotics Alone in Rabbit Model of Inhalational Anthrax
por: Kammanadiminti, Srinivas, et al.
Publicado: (2014)

Primary Involvement of Pharynx and Peyer's Patch in Inhalational and Intestinal Anthrax
por: Glomski, Ian J, et al.
Publicado: (2007)

Roles of Anthrax Toxin Receptor 2 in Anthrax Toxin Membrane Insertion and Pore Formation
por: Sun, Jianjun, et al.
Publicado: (2016)

Efficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease Severity
por: Yamamoto, Brent J., et al.
Publicado: (2016)

Estimation of Time Period for Effective Human Inhalational Anthrax Treatment Including Antitoxin Therapy
por: Rubinson, Lewis, et al.
Publicado: (2017)

Quantitative Models of the Dose-Response and Time Course of Inhalational Anthrax in Humans
por: Toth, Damon J. A., et al.
Publicado: (2013)

Treatment of Anthrax
Publicado: (1893)

Human Anthrax: Update of the Diagnosis and Treatment
por: Doganay, Mehmet, et al.
Publicado: (2023)

Converging physiological roles of the anthrax toxin receptors
por: Sergeeva, Oksana A., et al.
Publicado: (2019)

Exogenous Interferon-α and Interferon-γ Increase Lethality of Murine Inhalational Anthrax
por: Gold, Jeffrey A., et al.
Publicado: (2007)

Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.
por: Jernigan, J A, et al.
Publicado: (2001)

Isolated Case of Bioterrorism-related Inhalational Anthrax, New York City, 2001
por: Holtz, Timothy H., et al.
Publicado: (2003)

Inhalational Anthrax Outbreak among Postal Workers, Washington, D.C., 2001
por: Dewan, Puneet K., et al.
Publicado: (2002)

Anthrax Vaccines
por: Splino, Miroslav, et al.
Publicado: (2005)

Animal‐to‐Human Dose Translation of Obiltoxaximab for Treatment of Inhalational Anthrax Under the US FDA Animal Rule
por: Nagy, CF, et al.
Publicado: (2016)

Epidemiological Investigation of an Inhalational Anthrax Patient Traveling for Medical Treatment in Beijing Municipality, China, August 2021
por: Lin, Changying, et al.
Publicado: (2022)

Physiological Responses to Multiple Low-Doses of Bacillus anthracis Spores in the Rabbit Model of Inhalation Anthrax
por: Taft, Sarah C., et al.
Publicado: (2020)

First Case of Bioterrorism-Related Inhalational Anthrax, Florida, 2001: North Carolina Investigation
por: Maillard, Jean-Marie, et al.
Publicado: (2002)

Efficacy of ANTHRASIL (Anthrax Immune Globulin Intravenous (Human)) in rabbit and nonhuman primate models of inhalational anthrax: Data supporting approval under animal rule
por: Kammanadiminti, Srinivas, et al.
Publicado: (2023)

Alternative pre-approved and novel therapies for the treatment of anthrax
por: Head, Breanne M., et al.
Publicado: (2016)

Comprehensive characterization of toxins during progression of inhalation anthrax in a non-human primate model
por: Boyer, Anne E., et al.
Publicado: (2022)

Anthrax
por: Barritt, W. M.
Publicado: (1889)

Anthrax
por: Van Valkenburgh, Jacob
Publicado: (1877)

Anthrax
Publicado: (1895)

The Ins and Outs of Anthrax Toxin
por: Friebe, Sarah, et al.
Publicado: (2016)

Physiological Responses to a Single Low-Dose of Bacillus anthracis Spores in the Rabbit Model of Inhalational Anthrax
por: Taft, Sarah C., et al.
Publicado: (2020)

Oculocutaneous anthrax: detection and treatment
por: David, Sarada, et al.
Publicado: (2010)

Treatment of Human Anthrax with Penicillin
por: Ahmad, S.
Publicado: (1945)

Surgical Treatment of Cutaneous Anthrax
por: Zhao, Changsong, et al.
Publicado: (2019)

The Value of Prophylactic Treatment in Anthrax
por: Faust, John
Publicado: (1894)

The Potential Contributions of Lethal and Edema Toxins to the Pathogenesis of Anthrax Associated Shock
por: Hicks, Caitlin W., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_6c280hsjd86c75dkmd2abtnukr